Monovalent Influenza Vaccine

BIOLOGICAL2 trials

Sponsors

MedImmune LLC

Conditions

HealthyInfluenza

Phase 4

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season

CompletedNCT02743117

MedImmune LLCHealthy, Influenza

Start: 2016-05-02End: 2016-11-30Updated: 2017-10-04

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

CompletedNCT03158038

MedImmune LLCHealthy, Influenza

Start: 2017-05-30End: 2017-12-14Updated: 2019-01-04